You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 7, 2024

Copper cu-64 dotatate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for copper cu-64 dotatate and what is the scope of freedom to operate?

Copper cu-64 dotatate is the generic ingredient in one branded drug marketed by Radiomedix and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Copper cu-64 dotatate has eleven patent family members in six countries.

One supplier is listed for this compound.

Summary for copper cu-64 dotatate
International Patents:11
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 2
Clinical Trials: 1
DailyMed Link:copper cu-64 dotatate at DailyMed
Recent Clinical Trials for copper cu-64 dotatate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1

See all copper cu-64 dotatate clinical trials

Pharmacology for copper cu-64 dotatate

US Patents and Regulatory Information for copper cu-64 dotatate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Radiomedix DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Radiomedix DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Radiomedix DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Radiomedix DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Radiomedix DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for copper cu-64 dotatate

Country Patent Number Title Estimated Expiration
Poland 3536346 ⤷  Sign Up
Poland 2750717 ⤷  Sign Up
Denmark 2750717 ⤷  Sign Up
European Patent Office 2750717 TRACEUR TEP POUR L'IMAGERIE DE TUMEURS NEURO-ENDOCRINES (PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS) ⤷  Sign Up
Hungary E044625 ⤷  Sign Up
Spain 2732823 ⤷  Sign Up
Spain 2842998 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.